This is a preview of subscription content, log in via an institution to check access.
Notes
2015 US dollars
Reference
Parikh ND, et al. Survival and Cost-Effectiveness of Sorafenib Therapy in Advanced Hepatocellular Carcinoma: An Analysis of the SEER-Medicare Database. Hepatology : 22 Oct 2016. Available from: URL: http://doi.org/10.1002/hep.28881
Rights and permissions
About this article
Cite this article
Sorafenib not cost effective for HCC with decompensation. PharmacoEcon Outcomes News 765, 29 (2016). https://doi.org/10.1007/s40274-016-3514-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3514-2